ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 332 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $688,879 | -65.3% | 24,524 | -66.5% | 0.00% | -70.0% |
| Q3 2023 | $1,984,124 | -83.1% | 73,107 | -80.9% | 0.01% | -82.1% |
| Q2 2023 | $11,765,089 | -25.4% | 382,729 | -12.6% | 0.06% | -28.2% |
| Q1 2023 | $15,781,176 | -11.1% | 438,001 | -2.5% | 0.08% | -21.2% |
| Q4 2022 | $17,755,980 | +4284.2% | 449,291 | +3913.3% | 0.10% | +3200.0% |
| Q3 2021 | $405,000 | -85.9% | 11,195 | -84.0% | 0.00% | -85.0% |
| Q2 2021 | $2,865,000 | – | 69,905 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |